Healthy volunteers test new injector for arthritis drug
NCT ID NCT07007091
First seen Jan 04, 2026 · Last updated May 12, 2026 · Updated 16 times
Summary
This study tested a new on-body injector for risankizumab, a drug used for conditions like psoriasis and arthritis. 260 healthy adults received the drug either through the new injector or a standard syringe. Researchers measured how much drug got into the blood and how the body processed it to see if the two methods work the same way.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Acpru /Id# 276043
Grayslake, Illinois, 60030, United States
-
Cpmi /Id# 276490
Miami, Florida, 33172, United States
-
PPD Phase I Clinic /ID# 276525
Austin, Texas, 78744, United States
-
Ppd - Las Vegas Research Unit /ID# 276565
Las Vegas, Nevada, 89113, United States
Conditions
Explore the condition pages connected to this study.